SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-121726
Filing Date
2022-11-23
Accepted
2022-11-23 16:05:14
Documents
12
Period of Report
2022-11-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2231228d1_8k.htm   iXBRL 8-K 25293
  Complete submission text file 0001104659-22-121726.txt   197755

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA espr-20221123.xsd EX-101.SCH 3033
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE espr-20221123_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE espr-20221123_pre.xml EX-101.PRE 22595
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2231228d1_8k_htm.xml XML 3611
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 221416338
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences